BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MYC, c-Myc, 4609, ENSG00000136997
1775 results:

  • 1. myc and NCAPG2 as molecular targets of colorectal cancer and gastric cancer in nursing.
    Mi X; Shan H; Kang C; Zhang J; Hou S; Gao Y; Hao L; Gao X; Gao Q; Chi X; Zhang Q
    Medicine (Baltimore); 2024 May; 103(18):e38029. PubMed ID: 38701261
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of genes related to ribosomal proteins in colorectal cancer: exploring their potential as biomarkers, prognostic indicators, and therapeutic targets.
    Salehinia N; Mohammad Al-Mosawi AK; Al-Moussawi DK; Sadeghi ES; Zamani A; Mahdevar M
    Mol Biol Rep; 2024 Apr; 51(1):576. PubMed ID: 38664314
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation.
    Perri G; Vilas Boas VG; Nogueira MRS; Mello Júnior EJF; Coelho AL; Posadas EM; Hogaboam C; Cavassani KA; Campanelli AP
    Cancer Immunol Immunother; 2024 Apr; 73(6):110. PubMed ID: 38662248
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. STK16 promoted colorectal cancer progress in a c-myc signaling-dependent manner.
    Peng L; Guangshi L; Wusman LB; Tao L
    Mol Med; 2024 Apr; 30(1):50. PubMed ID: 38622518
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. BET inhibition induces synthetic lethality in PTEN deficient colorectal cancers via dual action on p21
    Ren G; Chen J; Pu Y; Yang EJ; Tao S; Mou PK; Chen LJ; Zhu W; Chan KL; Luo G; Deng C; Shim JS
    Int J Biol Sci; 2024; 20(6):1978-1991. PubMed ID: 38617536
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeting high circDNA2v levels in colorectal cancer induces cellular senescence and elicits an anti-tumor secretome.
    Wu S; Dai X; Xia Y; Zhao Q; Zhao H; Shi Z; Yin X; Liu X; Zhang A; Yao Z; Zhang H; Li Q; Thorne RF; Zhang S; Sheng W; Hu W; Gu H
    Cell Rep; 2024 Apr; 43(4):114111. PubMed ID: 38615319
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Structure-Guided Discovery and Preclinical Assessment of Novel (Thiophen-3-yl)aminopyrimidine Derivatives as Potent ERK1/2 Inhibitors.
    Shuai W; Xiao H; Yang P; Zhang Y; Bu F; Wu Y; Sun Q; Wang G; Ouyang L
    J Med Chem; 2024 Apr; 67(8):6425-6455. PubMed ID: 38613499
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways.
    D'Antona S; Porro D; Gallivanone F; Bertoli G
    Comput Biol Med; 2024 May; 174():108346. PubMed ID: 38581999
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tumoricidal properties of thymoquinone on human colorectal adenocarcinoma cells via the modulation of autophagy.
    Moulana MS; Haiaty S; Bazmani A; Shabkhizan R; Moslehian MS; Sadeghsoltani F; Mostafazadeh M; Asadi MR; Talebi M; Jafari Z; Morovati MR; Farzaei MH; Rahbarghazi R
    BMC Complement Med Ther; 2024 Mar; 24(1):132. PubMed ID: 38532470
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prediction of potential mechanisms of rhubarb therapy for colorectal cancer based on network pharmacological analysis and molecular docking.
    Yang F; Li X; Zhang Y; Ren Y; Zhang J; Xiao K
    Medicine (Baltimore); 2024 Mar; 103(12):e37477. PubMed ID: 38518016
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cinobufotalin regulates the USP36/c-myc axis to suppress malignant phenotypes of colon cancer cells
    Hu Y; Luo M
    Aging (Albany NY); 2024 Mar; 16(6):5526-5544. PubMed ID: 38517383
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer cells.
    Lin T; Zhang S; Tang Y; Xiao M; Li M; Gong H; Xie H; Wang Y
    BMC Cancer; 2024 Mar; 24(1):354. PubMed ID: 38504172
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The strain-dependent cytostatic activity of Lactococcus lactis on CRC cell lines is mediated through the release of arginine deiminase.
    Jastrząb R; Tomecki R; Jurkiewicz A; Graczyk D; Szczepankowska AK; Mytych J; Wolman D; Siedlecki P
    Microb Cell Fact; 2024 Mar; 23(1):82. PubMed ID: 38481270
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-myc/Nrf2 axis.
    Wang M; Hu S; Yang J; Yuan L; Han L; Liang F; Zhang F; Zhao H; Liu Y; Gao N
    Phytomedicine; 2024 May; 127():155391. PubMed ID: 38452690
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. scCircle-seq unveils the diversity and complexity of extrachromosomal circular DNAs in single cells.
    Chen JP; Diekmann C; Wu H; Chen C; Della Chiara G; Berrino E; Georgiadis KL; Bouwman BAM; Virdi M; Harbers L; Bellomo SE; Marchiò C; Bienko M; Crosetto N
    Nat Commun; 2024 Feb; 15(1):1768. PubMed ID: 38409079
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Efficacy of Butyrate to Inhibit Colonic cancer Cell Growth Is Cell Type-Specific and Apoptosis-Dependent.
    Oncel S; Safratowich BD; Lindlauf JE; Liu Z; Palmer DG; Briske-Anderson M; Zeng H
    Nutrients; 2024 Feb; 16(4):. PubMed ID: 38398853
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Kurarinone targets JAK2-STAT3 signaling in colon cancer-stem-like cells.
    Prajapati KS; Kumar S
    Cell Biochem Funct; 2024 Mar; 42(2):e3959. PubMed ID: 38390770
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming.
    Jones J; Shi Q; Nath RR; Brito IL
    PLoS One; 2024; 19(2):e0297897. PubMed ID: 38363784
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Stratification of colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 Tumours.
    Alfonsín G; Berral-González A; Rodríguez-Alonso A; Quiroga M; De Las Rivas J; Figueroa A
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339195
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer.
    Takei S; Tanaka Y; Lin YT; Koyama S; Fukuoka S; Hara H; Nakamura Y; Kuboki Y; Kotani D; Kojima T; Bando H; Mishima S; Ueno T; Kojima S; Wakabayashi M; Sakamoto N; Kojima M; Kuwata T; Yoshino T; Nishikawa H; Mano H; Endo I; Shitara K; Kawazoe A
    J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38336371
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 89.